Researchers Identify New Weak Spot in Glioblastoma, Potentially Enhancing Treatment

Researchers have found a potential new way to weaken glioblastoma, one of the deadliest brain cancers. Blocking a protein called SET prevented tumor formation in preclinical models, and targeting related proteins made cancer cells more vulnerable to radiation. This strategy aims to restore the activity of the PP2A enzyme, which glioblastoma cells typically suppress.